Specific In Vivo Deletion of B-Cell Subpopulations Expressing Human Immunoglobulins by the B-Cell Superantigen Protein L

AUTOR(ES)

Viau, Muriel

FONTE

American Society for Microbiology

RESUMO

Some pathogens have evolved to produce proteins, called B-cell superantigens, that can interact with human immunoglobulin variable regions, independently of the combining site, and activate B lymphocytes that express the target immunoglobulins. However, the in vivo consequences of these interactions on human B-cell numbers and function are largely unknown. Using transgenic mice expressing fully human immunoglobulins, we studied the consequences of in vivo exposure of protein L of Peptostreptococcus magnus with human immunoglobulins. In the mature pool of B cells, protein L exposure resulted in a specific reduction of splenic marginal-zone B cells and peritoneal B-1 cells. Splenic B cells exhibited a skewed light-chain repertoire consistent with the capacity of protein L to bind specific kappa gene products. Remarkably, these two B-cell subsets are implicated in innate B-cell immunity, allowing rapid clearance of pathogens. Thus, the present study reveals a novel mechanism that may be used by some infectious agents to subvert a first line of the host's immune defense.

Documentos Relacionados

• Normal serum immunoglobulins participate in the selection of peripheral B-cell repertoires.
• Identification of the protein encoded by the human diffuse B-cell lymphoma (dbl) oncogene.
• Mapping of B-cell epitopes of the human hepatitis B virus X protein.
• Single cell studies on the role of B-cell stimulatory factor 1 in B-cell activation.
• Induction of compartmentalized B-cell responses in human tonsils.